BGM Group Ltd. (BGM) income statement
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.13+0.00 (0.00%)
Close on Nov 18, 2026Market cap $3.26BP/E –Yield –
BGM Group Ltd. income statement
Ratios
Latest available, balances at Sep 30, 2025
Profitability, FY2025
- Gross margin
- 16.6%
- Operating margin
- -33.2%
- Net margin
- -52.6%
- Return on equity, FY2025
- -9.2%
Financial strength
- Current ratio
- 1.24
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 23.6%
Valuation
- P/E ratio
- –
- Price to sales
- 86.03
- Price to book
- 8.35
- Dividend yield
- –
See a number that looks wrong?